j4d5xminfy
III LIGA
Dołączył: 17 Lis 2010
Posty: 179
Przeczytał: 0 tematów
Ostrzeżeń: 0/5
Skąd: England
|
 Wysłany: Śro 9:58, 30 Mar 2011 |
|
|
Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Prescription Rate to Drive Revenues. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global dermatology therapeutics market. The report analyzes the markets for dermatology therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns and sales are forecast until 2016 for the key geographies as well as select therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.
Scope
The scope of this report includes:
- Annualized market data for the dermatology therapeutics market from 2001 to 2009, forecast forward to 2016
- Analysis of the leading therapeutic segments. These include Acne, Psoriasis [link widoczny dla zalogowanych], Dermatitis, Rosacea and Skin diseases.
- Analysis of the dermatology therapeutics market in the leading geographies of the world [link widoczny dla zalogowanych], which include the US, the UK, Germany, France, Italy [link widoczny dla zalogowanych] Spain, and Japan
- Market characterization of the dermatology therapeutics market including market size, annual cost of therapy, and treatment usage patterns
- Key drivers and barriers that have a significant impact on the market
- Coverage of pipeline molecules in various phases of drug development
- Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, GlaxoSmithKline, Leo Pharma, Sanofi-Aventis, Genentech, Novartis AG, Johnson & Johnson, Galderma Pharma SA, and Merck & Co, Inc.
- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global dermatology therapeutics market
For more information please contact :
/reports/The-Future-of-Dermatology-Therapeutics-Analysis-and-Market-Forecasts-to-2016-Increasing-Prescription-Rate-to-Drive-Revenues-39576.html
/
From:Aarkstore Enterprise
Contact: Neel
Email: [link widoczny dla zalogowanych]
URL:
Post został pochwalony 0 razy
|
|
